Markets
BSE See NSE See 37,363.43
809.83 (2.22%)

Cipla gets final nod for generic therapeutic equivalent of Tecfidera; stock opens 1.52 per cent higher

rishikesh gaikwad / Article rating: 5.0

Cipla Limited today announced that it has received final approval for its abbreviated new drug application (ANDA) for Dimethyl Fumarate DR Capsules 120mg, 240mg, and 120mg/240mg starter pack from United States Food & Drug Administration (USFDA).

12345678910Last

DSIJ MINDSHARE

12345Last